Remund, N.P.; Larsen, J.G.; Shin, M.J.; Warren, C.E.; Palmer, I.L.; Kim, I.J.; Cooper-Leavitt, E.T.; Clarke, D.M.; Beus, C.G.; Johnson, R.J.;
et al. The Role of Beta-Hydroxybutyrate in Mitigating the Inflammatory and Metabolic Consequences of Uric Acid. Metabolites 2024, 14, 679.
https://doi.org/10.3390/metabo14120679
AMA Style
Remund NP, Larsen JG, Shin MJ, Warren CE, Palmer IL, Kim IJ, Cooper-Leavitt ET, Clarke DM, Beus CG, Johnson RJ,
et al. The Role of Beta-Hydroxybutyrate in Mitigating the Inflammatory and Metabolic Consequences of Uric Acid. Metabolites. 2024; 14(12):679.
https://doi.org/10.3390/metabo14120679
Chicago/Turabian Style
Remund, Nicole P., John G. Larsen, Marley J. Shin, Cali E. Warren, Isabelle L. Palmer, Iris J. Kim, Elijah T. Cooper-Leavitt, Derek M. Clarke, Colson G. Beus, Richard J. Johnson,
and et al. 2024. "The Role of Beta-Hydroxybutyrate in Mitigating the Inflammatory and Metabolic Consequences of Uric Acid" Metabolites 14, no. 12: 679.
https://doi.org/10.3390/metabo14120679
APA Style
Remund, N. P., Larsen, J. G., Shin, M. J., Warren, C. E., Palmer, I. L., Kim, I. J., Cooper-Leavitt, E. T., Clarke, D. M., Beus, C. G., Johnson, R. J., Arroyo, J. A., Reynolds, P. R., & Bikman, B. T.
(2024). The Role of Beta-Hydroxybutyrate in Mitigating the Inflammatory and Metabolic Consequences of Uric Acid. Metabolites, 14(12), 679.
https://doi.org/10.3390/metabo14120679
